MidFirst Bank’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
MidFirst Bank's NVO Position: Q3 2026 in Review
MidFirst Bank held its Novo Nordisk (NVO) position steady in Q3 2026 at 241 shares worth $9.14K. The position accounts for ﹤0.01% of the portfolio, ranked #516.
MidFirst Bank first reported a position in NVO in Q4 2025 and has held it in 4 quarters since. The position peaked at $381K in Q4 2025. 1,227 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- MidFirst Bank held 241 shares of Novo Nordisk worth $9.14K as of Q3 2026.
- MidFirst Bank left its Novo Nordisk share count unchanged in Q3 2026.
- Novo Nordisk made up ﹤0.01% of MidFirst Bank's portfolio in Q3 2026, its #516 holding.
- MidFirst Bank first reported a position in Novo Nordisk in Q4 2025 and has held it in 4 quarters since.
- MidFirst Bank's Novo Nordisk position peaked at $381K in Q4 2025.
- 1,227 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on MidFirst Bank's 13F filing for Q3 2026, filed 16 Nov 2026.